The orphan nuclear receptors in cancer and diabetes

Journal of Receptors and Signal Transduction

Volumn 33, Issue 4, 2013, Pages 207-212

  Ranhotra, Harmit S ^a  

^a St Edmund's College   (India)

Author keywords

Cancer; Diabetes; Gluconeogenesis; Glycolysis; Orphan nuclear receptors

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; ESTROGEN RELATED RECEPTOR ALPHA; NUCLEAR RECEPTOR DAX 1; ORPHAN NUCLEAR RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PYRUVATE DEHYDROGENASE COMPLEX; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; LIGAND;

ADIPOGENESIS; ARTICLE; CELL PROLIFERATION; DIABETES MELLITUS; DNA RESPONSIVE ELEMENT; ENERGY METABOLISM; ESTROGEN RESPONSIVE ELEMENT; GENE CONTROL; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCOGENOLYSIS; HORMONAL REGULATION; HUMAN; LIPID METABOLISM; NEOPLASM; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STEROIDOGENESIS; GENE EXPRESSION REGULATION; GENETICS; GLYCOLYSIS; METABOLISM; PATHOLOGY;

DIABETES MELLITUS; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; GLYCOLYSIS; HUMANS; LIGANDS; NEOPLASMS; ORPHAN NUCLEAR RECEPTORS;

EID: 84880883971     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2013.781624     Document Type: Article

References (63)

1. Giguere V. Orphan nuclear receptors: From gene to function. Endocr Rev 1999;20:689-725
2. Benoit G, Cooney A, Giguere V, et al. International Union of Pharmacology. LXVI. Orphan nuclear receptors. Pharmacol Rev 2006;58:798-836
3. Giguere V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr Rev 2008;29:677-96
4. Schmidt DR, Mangelsdorf DJ. Nuclear receptors of the enteric tract: Guarding the frontier. Nutr Rev 2008;66:S88-97
5. Shiau AK, Coward P, Schwarz M, Lehmann JM. Orphan nuclear receptors: From new ligand discovery technologies to novel signaling pathways. Curr Opin Drug Discov Devel 2001; 4:575-90
6. Novac N, Heinzel T. Nuclear receptors: Overview and classification. Curr Drug Targets Inflamm Allergy 2004;3:335-46
7. Germain P, Chambon P, Eichele G, et al. International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol Rev 2006; 58:760-72
8. Germain P, Chambon P, Eichele G, et al. International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev 2006; 58:712-25
9. Dahlman-Wright K, Cavailles V, Fuqua SA, et al. International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 2006;58:773-81
10. Francis GA, Fayard E, Picard F, Auwerx J. Nuclear receptors and the control of metabolism. Annu Rev Physiol 2003;65:261-311
11. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 2001;81:1269-304
12. Ranhotra HS. The interplay between retinoic acid receptor-related orphan receptors and human diseases. J Recept Signal Transduct 2012;32:181-9
13. Ranhotra HS. The mammalian orphan nuclear receptors: Orphans as cellular guardians. J Recept Signal Transduct 2011;31:20-5
14. Pearen MA, Muscat GE. Orphan nuclear receptors and the regulation of nutrient metabolism: Understanding obesity. Physiology (Bethesda) 2012;27:156-66
15. Burris TP, Busby SA, Griffin PR. Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity. Chem Biol 2012;19:51-9
16. Ranhotra HS. The estrogen-related receptors: Orphans orchestrating myriad functions. J Recept Signal Transduct 2012; 32:47-56
17. Ranhotra HS. The estrogen-related receptor alpha: The oldest, yet an energetic orphan with robust biological functions. J Recept Signal Transduct 2010;30:193-205
18. Deblois G, St-Pierre J, Giguère V. The PGC-1/ERR signaling axis in cancer. Oncogene 2012 (published online, ahead of print
19. Deblois G, Giguère V. Oestrogen-related receptors in breast cancer: Control of cellular metabolism and beyond. Nat Rev Cancer 2013;13:27-36
20. Cai Q, Lin T, Kamarajugadda S, Lu J. Regulation of glycolysis and the Warburg effect by estrogen-related receptors. Oncogene 2012 (published online, ahead of print
21. Chang CY, McDonnell DP. Molecular pathways: The metabolic regulator estrogen-related receptor a as a therapeutic target in cancer. Clin Cancer Res 2012;18:6089-95
22. Zhao Y, Li Y, Lou G, et al. MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells. PLoS One 2012;7:e39102
23. Qin J, Chen X, Xie X, et al. COUP-TFII regulates tumor growth and metastasis by modulating tumor angiogenesis. Proc Natl Acad Sci USA 2010;107:3687-92
24. Qin J, Chen X, Yu-Lee LY, et al. Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling. Cancer Res 2010;70:8812-21
25. Litchfield LM, Klinge CM. Multiple roles of COUP-TFII in cancer initiation and progression. J Mol Endocrinol 2012;49: R135-48
26. Song CH, Lee HJ, Park E, Lee K. The chicken ovalbumin upstream promoter-Transcription factor II negatively regulates the transactivation of androgen receptor in prostate cancer cells. PLoS One 2012;7:e49026
27. Qin J, Wu SP, Creighton CJ, et al. COUP-TFII inhibits TGFb-induced growth barrier to promote prostate tumorigenesis. Nature 2013;493:236-40
28. Chand AL, Herridge KA, Thompson EW, Clyne CD. The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion. Endocr Relat Cancer 2010;17:965-75
29. Thiruchelvam PT, Lai CF, Hua H, et al. The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells. Breast Cancer Res Treat 2011;127:385-96
30. Chand AL, Wijayakumara DD, Knower KC, et al. The orphan nuclear receptor LRH-1 and ERa activate GREB1 expression to induce breast cancer cell proliferation. PLoS One 2012;7: E31593
31. Chand AL, Herridge KA, Howard TL, et al. Tissue-specific regulation of aromatase promoter II by the orphan nuclear receptor LRH-1 in breast adipose stromal fibroblasts. Steroids 2011;76: 741-4
32. Mendiola M, Carrillo J, García E, et al. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors. Int J Cancer 2006;118: 1381-9
33. García-Aragoncillo E, Carrillo J, Lalli E, et al. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cellcycle progression in Ewing's tumor cells. Oncogene 2008;27: 6034-43
34. Bavner A, Sanyal S, Gustafsson JA, Treuter E. Transcriptional corepression by SHP: Molecular mechanisms and physiological consequences. Trends Endocrinol Metab 2005;16:478-88
35. Yang Z, Zhang Y, Kemper JK, Wang L. Cross-regulation of protein stability by p53 and nuclear receptor SHP. PLoS One 2012;7: E39789
36. Zhang Y, Xu P, Park K, et al. Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation. Hepatology 2008;48:289-98
37. He N, Park K, Zhang Y, et al. Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth. Gastroenterology 2008;134: 793-802
38. Zhang Y, Soto J, Park K, et al. Nuclear receptor SHP, a death receptor that targets mitochondria, induces apoptosis and inhibits tumor growth. Mol Cell Biol 2010;30:1341-56
39. Zhang Y, Hagedorn CH, Wang L. Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta 2011;1812: 893-908
40. Seol W, Hanstein B, Brown M, Moore DD. Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner). Mol Endocrinol 1998;12:1551-7
41. Johansson L, Thomsen JS, Damdimopoulos AE, et al. The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta. J Biol Chem 1999;274:345-53
42. Kovacic A, Speed CJ, Simpson ER, Clyne CD. Inhibition of aromatase transcription via promoter II by short heterodimer partner in human preadipocytes. Mol Endocrinol 2004;18:252-9
43. Deutsch AJ, Angerer H, Fuchs TE, Neumeister P. The nuclear orphan receptors NR4A as therapeutic target in cancer therapy. Anticancer Agents Med Chem 2012;12:1001-14
44. Mohan HM, Aherne CM, Rogers AC, et al. Molecular pathways: The role of NR4A orphan nuclear receptors in cancer. Clin Cancer Res 2012;18:3223-8
45. McMorrow JP, Murphy EP Inflammation: A role for NR4A orphan nuclear receptors? Biochem Soc Trans 2011;39:688-93
46. Jetten AM. Retinoid-related orphan receptors (RORs): Critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal 2009;7:e003
47. Kim DK, Ryu D, Koh M, et al. Orphan nuclear receptor estrogenrelated receptor g (ERRg) is key regulator of hepatic gluconeogenesis. J Biol Chem 2012;287:21628-39
48. Jeong JY, Jeoung NH, Park KG, Lee IK. Transcriptional regulation of pyruvate dehydrogenase kinase. Diabetes Metab J 2012;36: 328-35
49. Zhang Y, Ma K, Sadana P, et al. Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression. J Biol Chem 2006;281:39897-906
50. Pei L, Waki H, Vaitheesvaran B, et al. NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat Med 2006;12:1048-55
51. Berriel Diaz M, Lemke U, Herzig S. Discovering orphans' sweet secret: NR4A receptors and hepatic glucose production. Cell Metab 2006;4:339-40
52. Fu Y, Luo L, Luo N, et al. NR4A orphan nuclear receptors modulate insulin action and the glucose transport system: Potential role in insulin resistance. J Biol Chem 2007;282:31525-33
53. Pearen MA, Muscat GE. Minireview: Nuclear hormone receptor 4A signaling: Implications for metabolic disease. Mol Endocrinol 2010;24:1891-903
54. Myers SA, Eriksson N, Burow R, et al. b-Adrenergic signaling regulates NR4A nuclear receptor and metabolic gene expression in multiple tissues. Mol Cell Endocrinol 2009;309:101-8
55. Kanzleiter T, Schneider T, Walter I, et al. Evidence for Nr4a1 as a cold-induced effector of brown fat thermogenesis. Physiol Genomics 2005;24:37-44
56. Chao LC, Wroblewski K, Ilkayeva OR, et al. Skeletal muscle Nur77 expression enhances oxidative metabolism and substrate utilization. J Lipid Res 2012;53:2610-19
57. Miao J, Xiao Z, Kanamaluru D, et al. Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation. Genes Dev 2009; 23:986-96
58. Yang Z, Wu S, Zheng T, et al. Gender-dependent penetrance of small heterodimer partner (SHP) gene deficiency in overweight/obese Chinese pedigrees. J Int Med Res 2010;38: 142-9
59. Enya M, Horikawa Y, Kuroda E, et al. Mutations in the small heterodimer partner gene increase morbidity risk in Japanese type 2 diabetes patients. Hum Mutat 2008;29:E271-7
60. Moore DD. Nuclear receptors reverse McGarry's vicious cycle to insulin resistance. Cell Metab 2012;15:615-22
61. Kim YD, Park KG, Lee YS, et al. Metformin inhibits hepatic gluconeogenesis through AMP-Activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 2008; 57: 306-14
62. Meissburger B, Ukropec J, Roeder E, et al. Adipogenesis and insulin sensitivity in obesity are regulated by retinoidrelated orphan receptor gamma. EMBO Mol Med 2011;3: 637-51
63. Tinahones FJ, Moreno-Santos I, Vendrell J, et al. The retinoic acid receptor-related orphan nuclear receptor g1 (RORg1): A novel player determinant of insulin sensitivity in morbid obesity. Obesity (Silver Spring) 2012;20:488-97